Noninvasive ventilation for obesity hypoventilation syndrome
Obesity hypoventilation syndrome (OHS) is defined as a combination of obesity, daytime hypercapnia (increased carbon dioxide levels) and hypoxia (oxygen deprivation) during sleep after ruling out other disorders that may cause alveolar hypoventilation.
OHS is a chronic condition that has been linked with metabolic, hormonal and cardiovascular deficiencies. It has been shown to decrease quality of life and carries an increased risk of hospitalisation and death.1
The use of noninvasive ventilation in OHS patients has been shown to:
- Normalise blood gases2
- Prolong survival2
- Decrease pulmonary artery systolic pressure3
- Increase exercise capacity3
Find out more about noninvasive ventilation on our dedicated ResMed page.